Originating from world’s leading exposome research laboratory
Spinning out of Mount Sinai Health System, New York, an NIH Center and reference laboratory for the novel frontier science.
Enables characterization of biological pathways beyond what genomics can do
Linus data science can incorporate genomic and other -omic datasets into their exposomics pipeline.
Precision exposome medicine = “deep phenotyping”
A scientific breakthrough with the potential to transform the diagnosis and treatment of disease, as sequencing for mutations in genomics began to do 25 years ago.
“Sequencing the exposome and biological response at a molecular level using our propriety environmental biodynamics platform is furthering our understanding of disease through a completely novel approach”
Manish Arora, PhD, BDS, MPH, co-founder, CEO and CSO of Linus Biotechnology